Skip to content

Drug interactions

Lomitapide + Ondansetron

Severity: Minor

Lomitapide and Ondansetron: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Lomitapide inhibits P-glycoprotein and could raise exposure to P-gp substrates. Ondansetron is a P-gp substrate, so its concentrations and QT effect may increase modestly.

What this interaction means in plain words

Lomitapide and Ondansetron have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Lomitapide belongs to Cardiovascular; Ondansetron belongs to Gastrointestinal Tract.

Evidence level: Low

Why it happens

P-glycoprotein inhibition by lomitapide may reduce ondansetron efflux.

What to do

Use the lowest effective ondansetron dose and monitor for adverse effects such as QT prolongation in patients with risk factors.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Lomitapide and Ondansetron, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Lomitapide with Ondansetron?

MediHelp rates the interaction as minor. Lomitapide and Ondansetron have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Lomitapide inhibits P-glycoprotein and could raise exposure to P-gp substrates. Ondansetron is a P-gp substrate, so its concentrations and QT effect may increase modestly.

How serious is the interaction between Lomitapide and Ondansetron?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Use the lowest effective ondansetron dose and monitor for adverse effects such as QT prolongation in patients with risk factors.

What other medicines interact with Ondansetron?

MediHelp also lists interactions of Ondansetron with, for example, Apomorphine, Thioridazine, Vandetanib. The full list is on the Ondansetron page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in